Long-term, Open-label, Multicenter Study Assessing Long-term Cardiovascular Risks

Summary

This study will evaluate if patients who had a serious cardiovascular event upon initiation of fingolimod are at risk to delevop long term other cardiovascular events

Timeline

Start

2014-09-29

Primary completion

2020-01-24

Completion

2020-01-24

Drugs

Indications